Gene-dosage effects in Down syndrome and trisomic mouse models
-
Correspondence: Katheleen Gardiner kgardine@du.edu
Genome Biology 2004, 5:244 doi:10.1186/gb-2004-5-10-244
Accesses
- Last 30 days: 62 accesses
- Last year: 988 accesses
- All time: 5544 accesses
Cited by
BioMed Central: 2 citations
|
Anna Conti, Floriana Fabbrini, Paola D'Agostino, Rosa Negri, Dario Greco, Rita Genesio, Maria D'Armiento, Carlo Olla, Dario Paladini, Mariastella Zannini, Lucio Nitsch BMC Genomics 2007, 8:268 (7 August 2007) |
|
Chi-Ming Li, Meirong Guo, Martha Salas, Nicole Schupf, Wayne Silverman, Warren B Zigman, Sameera Husain, Dorothy Warburton, Harshwardhan Thaker, Benjamin Tycko BMC Medical Genetics 2006, 7:24 (15 March 2006) Differential over-expression of chromosome 21 genes in trisomy 21 fibroblasts and fetal hearts may help explain the occurrence of cardiac defects and autoimmune diseases in patients with Down syndrome.
|